Article Original Full-Text Article Original Full-Text Articles en version intégrale en partenariat avec des revues scientifiques de renommée internationales et nationales.

Preventive treatment with vigabatrin was safe and reduced the risk and severity of epilepsy in infants with tuberous sclerosis complex

Abstract

Objective: Epilepsy develops in 70 to 90% of children with tuberous sclerosis complex (TSC) and is often resistant to medication. Recently, the concept of preventive antiepileptic treatment to modify the natural history of epilepsy has been proposed. EPISTOP was a clinical trial designed to compare preventive versus conventional antiepileptic treatment in TSC infants.